SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11773157
Source:
http://linkedlifedata.com/resource/pubmed/id/11773157
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0034866
,
umls-concept:C0079809
,
umls-concept:C0123931
,
umls-concept:C0449297
,
umls-concept:C1523987
pubmed:issue
1
pubmed:dateCreated
2002-1-4
pubmed:abstractText
To evaluate relationships between various body-size measures and irinotecan (CPT-11) clearance and metabolism in cancer patients, and to provide future dosing recommendations for this agent.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11773157-11773147
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic
,
http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin
,
http://linkedlifedata.com/resource/pubmed/chemical/irinotecan
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0732-183X
pubmed:author
pubmed-author:MathijssenRon H JRH
,
pubmed-author:NooterKeesK
,
pubmed-author:SparreboomAlexA
,
pubmed-author:StoterGerritG
,
pubmed-author:VerweijJaapJ
,
pubmed-author:de JongeMaja J AMJ
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
81-7
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:11773157-Adult
,
pubmed-meshheading:11773157-Aged
,
pubmed-meshheading:11773157-Antineoplastic Agents, Phytogenic
,
pubmed-meshheading:11773157-Body Constitution
,
pubmed-meshheading:11773157-Body Surface Area
,
pubmed-meshheading:11773157-Camptothecin
,
pubmed-meshheading:11773157-Colorectal Neoplasms
,
pubmed-meshheading:11773157-Dose-Response Relationship, Drug
,
pubmed-meshheading:11773157-Female
,
pubmed-meshheading:11773157-Humans
,
pubmed-meshheading:11773157-Infusions, Intravenous
,
pubmed-meshheading:11773157-Linear Models
,
pubmed-meshheading:11773157-Male
,
pubmed-meshheading:11773157-Metabolic Clearance Rate
,
pubmed-meshheading:11773157-Middle Aged
,
pubmed-meshheading:11773157-Multivariate Analysis
,
pubmed-meshheading:11773157-Netherlands
,
pubmed-meshheading:11773157-Retrospective Studies
pubmed:year
2002
pubmed:articleTitle
Impact of body-size measures on irinotecan clearance: alternative dosing recommendations.
pubmed:affiliation
Department of Medical Oncology, Rotterdam Cancer Institute (Daniel den Hoed Kliniek), 3008 AE Rotterdam, the Netherlands.
pubmed:publicationType
Journal Article